Aversive Procedures in Behavior Analysis: Stakeholder Perspectives, Policy, and Ethical Practice

Overview & Clinical Significance

The use of aversive procedures in behavior support, particularly contingent electric skin shock (CESS), remains one of the most contentious and ethically charged issues in the field of behavior analysis. This topic sits at the intersection of clinical practice, human rights advocacy, public policy, and professional ethics. For BCBAs, understanding the current landscape of stakeholder perspectives and policy efforts is not merely an academic exercise. It directly informs how we conceptualize our ethical obligations to clients, how we engage with advocacy efforts, and how we position ourselves as professionals in an evolving societal conversation about the treatment of individuals with developmental disabilities.

The clinical significance of this topic extends beyond the relatively small number of individuals currently receiving CESS. The broader conversation about aversive procedures touches every behavior analyst's practice because it raises fundamental questions about the criteria we use when selecting interventions, how we weigh efficacy against potential harm, and whose voices should inform treatment decisions. When stakeholders, including autistic self-advocates, family members, clinicians, and policymakers, report their perspectives on aversive procedures, those perspectives provide data that behavior analysts are ethically obligated to consider.

NYSABA's investigation into stakeholder perspectives represents a systematic effort to gather and analyze these viewpoints. By conducting statewide surveys and engaging with diverse stakeholder groups, the organization has created an empirical foundation for advocacy efforts that goes beyond anecdotal accounts or philosophical arguments. This approach models the kind of evidence-based advocacy that behavior analysts should bring to policy discussions, using data to inform positions rather than relying solely on professional opinion.

The Shining a Light initiative represents a coordinated coalition-building effort that brings together stakeholders from multiple perspectives to advocate for the elimination of CESS and the expansion of affirming, evidence-based services. For BCBAs, this initiative illustrates how professional organizations can translate ethical principles into concrete policy action. Understanding these efforts is essential for practitioners who want to contribute meaningfully to the ongoing evolution of ethical standards in the field.

Background & Context

The history of aversive procedures in behavior analysis is deeply intertwined with the field's development. Early behavioral interventions frequently employed aversive stimuli, including electric shock, as components of behavior reduction programs. Over the ensuing decades, the field underwent a significant philosophical and ethical shift, with the development of positive behavioral support approaches and an increasing recognition that effective behavior change can be achieved through reinforcement-based strategies in the vast majority of cases.

Despite this broader shift, CESS has continued to be used at a small number of facilities, most notably the Judge Rotenberg Center in Massachusetts. The persistence of CESS has generated sustained controversy, with the FDA issuing a final rule banning electrical stimulation devices for self-injurious or aggressive behavior in 2020, though this rule was subsequently vacated by a federal court in 2021. This regulatory back-and-forth has highlighted the complexity of eliminating aversive procedures through federal policy alone and has driven state-level advocacy efforts like those in New York.

In New York State, the conversation about aversive procedures exists within a broader context of service availability and quality. Many families of individuals with significant developmental support needs report difficulty accessing appropriate services, including intensive behavioral support, crisis intervention, and community-based alternatives to institutional care. Advocates argue that the continued use of CESS is, in part, a symptom of systemic failures to provide adequate positive behavioral support services. When families feel they have exhausted all other options, the appeal of any intervention that promises behavior reduction becomes understandable, even if the intervention carries significant ethical concerns.

NYSABA's statewide survey sought to capture this complexity by gathering data from multiple stakeholder groups, including behavior analysts, other professionals, family members, and self-advocates. The survey findings provide a nuanced picture of how different groups perceive aversive procedures, what barriers they identify to accessing affirming services, and what policy changes they believe would be most impactful. This data-driven approach to advocacy reflects the scientific values of the field while centering the voices of those most affected by treatment decisions.

Legislative engagement has been a key component of NYSABA's strategy. By meeting with legislators, presenting survey data, and building coalitions with other advocacy organizations, NYSABA has modeled how professional organizations can translate ethical commitments into policy change. The strategic plan to eliminate CESS involves multiple pathways, including legislative action, regulatory reform, expanded service availability, and professional education.

Clinical Implications

The clinical implications of the aversive procedures debate extend to every behavior analyst who develops behavior reduction programs. Even practitioners who have never considered using CESS are affected by the broader conversation about how we select interventions, how we document the rationale for our choices, and how we ensure that less restrictive alternatives have been thoroughly explored before implementing any aversive procedure.

The principle of least restrictive effective treatment is foundational to ethical behavior analytic practice. This principle requires that practitioners systematically evaluate and attempt less restrictive interventions before considering more restrictive approaches. However, the practical application of this principle is often more complex than it appears. Determining what constitutes a thorough attempt at less restrictive alternatives, establishing appropriate timelines for evaluating intervention effectiveness, and defining the threshold at which more restrictive procedures become justified all require clinical judgment informed by ethical reasoning.

For practitioners working with individuals who display severe self-injurious or aggressive behavior, the aversive procedures debate has direct clinical relevance. These practitioners must navigate the tension between their ethical obligation to provide effective treatment and their equally important obligation to protect clients from unnecessary harm. The growing evidence base for reinforcement-based approaches to severe behavior, including functional communication training, differential reinforcement, antecedent modifications, and comprehensive behavioral support plans, provides a strong foundation for reducing reliance on aversive procedures.

The stakeholder perspective data collected by organizations like NYSABA should inform clinical decision-making. When self-advocates consistently report that aversive procedures are harmful and traumatizing, this information constitutes social validity data that behavior analysts must weigh alongside efficacy data. The field's historical tendency to prioritize immediate behavior reduction over long-term psychological well-being and client dignity is being challenged by stakeholder voices that demand a more holistic consideration of treatment outcomes.

Clinicians should also consider the systemic factors that contribute to the perceived need for aversive procedures. Inadequate staffing ratios, insufficient training in positive behavioral support, lack of access to board-certified behavior analysts, and systemic failures in crisis prevention all contribute to situations where aversive procedures may appear to be the only viable option. Addressing these systemic factors is ultimately more effective and ethical than relying on aversive interventions to manage the consequences of inadequate support systems.

The clinical implications also extend to how behavior analysts communicate about behavior reduction procedures with stakeholders. Transparent communication about the risks, benefits, and alternatives to any restrictive procedure is an ethical requirement. Families and caregivers deserve complete information presented in accessible language to make informed decisions about their loved ones' treatment.

Ethical Considerations

The ethical dimensions of aversive procedures are among the most complex in behavior analysis. The Ethics Code for Behavior Analysts (2022) provides a framework for navigating these issues, though the application of ethical principles to specific situations requires careful analysis and professional judgment.

Code 2.01 (Providing Effective Treatment) creates a tension that practitioners must resolve. On one hand, behavior analysts are obligated to provide treatments that are effective. On the other hand, effectiveness cannot be the sole criterion for intervention selection. The potential for harm, the availability of alternatives, client preferences, and societal values all factor into ethical treatment decisions. When aversive procedures produce immediate behavior reduction but carry risks of physical harm, psychological trauma, or damage to the therapeutic relationship, the calculus of effectiveness becomes considerably more complex.

Code 2.14 (Selecting, Designing, and Implementing Behavior-Change Interventions) requires that behavior analysts consider the least restrictive procedures and the impact on the client when selecting interventions. This code operationalizes the principle of least restrictive treatment and places the burden on the practitioner to document that less restrictive alternatives have been attempted and found insufficient before considering more restrictive procedures. The documentation requirement is not merely administrative. It represents a safeguard designed to prevent premature escalation to restrictive interventions.

Code 2.15 (Minimizing Risk of Behavior-Change Interventions) specifically addresses the obligation to minimize risk associated with behavior-change procedures. When aversive procedures carry inherent risks of physical injury or psychological harm, this code requires practitioners to implement robust safeguards, monitor for adverse effects, and maintain ongoing assessment of whether the procedure remains justified given the client's current presentation.

Code 3.01 (Behavior-Analytic Assessment) requires that intervention decisions be informed by thorough assessment. In the context of aversive procedures, this means conducting comprehensive functional assessments that identify the environmental variables maintaining challenging behavior and using those findings to develop function-based interventions before considering any aversive approach. A behavior reduction program that relies on aversive procedures without a thorough functional assessment fails to meet this ethical standard.

The role of behavior analysts in policy advocacy raises additional ethical considerations. Code 4.07 (Promoting an Ethical Culture) encourages behavior analysts to promote ethical practices within organizations and systems. For practitioners who believe that aversive procedures are ethically unjustifiable, this code supports engagement in advocacy efforts aimed at policy change. However, advocacy must be grounded in data and ethical reasoning rather than emotional appeals or ideological positions.

The voices of individuals who have experienced aversive procedures are ethically paramount. Code 2.02 (Timeliness) and Code 1.07 (Cultural Responsiveness and Diversity) together emphasize the importance of responsive, individualized, and respectful service delivery. Listening to and centering the experiences of those who have been subject to aversive procedures is not only good practice but an ethical obligation for a field that claims to serve these individuals' best interests.

Assessment & Decision-Making

The decision-making process around restrictive and aversive procedures should follow a systematic, documented framework that ensures thoroughness and accountability. Behavior analysts must approach these decisions with both scientific rigor and ethical sensitivity.

The assessment process begins with a comprehensive functional behavior assessment (FBA) that identifies the environmental variables maintaining the challenging behavior. This assessment should include multiple methods, such as indirect assessment through interviews and rating scales, direct observation using descriptive analysis, and when feasible and appropriate, functional analysis. The goal is to develop a clear understanding of the behavioral function that can inform the design of function-based interventions. Without this foundational assessment, any intervention selection, including both positive and aversive approaches, lacks empirical justification.

Once the functional assessment is complete, the treatment planning process should systematically evaluate positive, reinforcement-based interventions that address the identified function. This evaluation should consider functional communication training, differential reinforcement procedures, antecedent modifications, environmental restructuring, and skill-building programs. Each alternative should be implemented with sufficient intensity and fidelity before being judged ineffective. Too often, less restrictive alternatives are attempted half-heartedly or for insufficient durations, leading to premature conclusions about their ineffectiveness.

Stakeholder input is a critical component of the decision-making process. Families, caregivers, the individuals themselves when possible, and interdisciplinary team members should all contribute to treatment decisions. Their perspectives provide essential context about the impact of behavior on daily life, the acceptability of proposed interventions, and the priorities that should guide treatment. The Shining a Light initiative's emphasis on stakeholder perspectives models this inclusive approach to decision-making.

Risk-benefit analysis should be formally documented for any proposed restrictive procedure. This analysis should consider the severity and frequency of the target behavior, the specific risks associated with the proposed procedure, the documented outcomes of less restrictive alternatives that have been attempted, the potential impact on the therapeutic relationship, the client's own preferences and responses, and the availability of supports needed to implement the procedure safely. This analysis should be reviewed and updated regularly as the client's presentation changes.

Human rights committees and peer review panels serve as important safeguards in the decision-making process. These bodies provide an external check on clinical judgment and help ensure that decisions to implement restrictive procedures are justified, well-documented, and subject to ongoing oversight. Behavior analysts should advocate for the establishment and maintenance of these oversight structures within their organizations.

Finally, the assessment and decision-making process should include a clear plan for fading or eliminating any restrictive procedure that is implemented. The goal should always be to transition the individual to less restrictive support as quickly as possible, with ongoing data collection to guide the fading process.

What This Means for Your Practice

Regardless of whether you ever encounter a clinical situation involving CESS or other aversive procedures, the themes of this topic apply directly to your daily practice. Every behavior analyst develops behavior reduction programs, and the principles of least restrictive treatment, thorough functional assessment, stakeholder engagement, and documentation apply universally.

Review your current behavior reduction programs with fresh eyes. Are you documenting the rationale for your intervention selections? Have you thoroughly explored and documented the outcomes of less restrictive alternatives? Are you actively seeking and incorporating stakeholder perspectives, including the preferences and responses of the individuals you serve? These questions apply whether you are implementing a simple differential reinforcement program or a more complex behavior support plan.

Consider your role in advocacy and policy. The behavior analytic community's response to aversive procedures is shaped by the collective actions of individual practitioners. You can contribute by staying informed about policy developments, supporting professional organizations that advocate for evidence-based and affirming practices, engaging with legislators when opportunities arise, and modeling ethical practice in your own work.

Invest in your competency in positive behavioral support approaches for severe behavior. The strongest argument against aversive procedures is the demonstrated effectiveness of alternatives. By building your skills in functional assessment, function-based intervention, crisis prevention, and trauma-informed care, you strengthen both your individual practice and the field's collective capacity to serve individuals with significant support needs without resorting to aversive procedures.

Engage with the perspectives of autistic self-advocates and individuals with developmental disabilities. Their lived experiences provide essential context for clinical decision-making and policy development. Seek out first-person accounts, attend presentations by self-advocates, and incorporate their perspectives into your professional development.